Glycosylation News and Research

RSS
Researchers identify a new mechanism underlying atherosclerosis

Researchers identify a new mechanism underlying atherosclerosis

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Basigin does not facilitate SARS-CoV-2 entry, say researchers

Basigin does not facilitate SARS-CoV-2 entry, say researchers

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

An overview of spike protein antigen COVID-19 vaccine candidates

An overview of spike protein antigen COVID-19 vaccine candidates

Evolution of the spike gene of SARS-CoV-2 for human adaptation

Evolution of the spike gene of SARS-CoV-2 for human adaptation

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

A glycan controls how SARS-CoV-2’s spike protein opens, study finds

A glycan controls how SARS-CoV-2’s spike protein opens, study finds

SARS-CoV-2 D614G mutation associated with lower antibody binding

SARS-CoV-2 D614G mutation associated with lower antibody binding

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

New mouse model of SARS-CoV-2 infection reflects features of human infection

New mouse model of SARS-CoV-2 infection reflects features of human infection

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

New research aims to explore functions of bile acids in the gut stem cell niche

New research aims to explore functions of bile acids in the gut stem cell niche

Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro

Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

Genetic interactions may shed light on NGLY1 deficiency

Genetic interactions may shed light on NGLY1 deficiency

Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19

Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19

Researchers use SARS-CoV-2 to bioengineer universal vaccine platform

Researchers use SARS-CoV-2 to bioengineer universal vaccine platform

Researchers develop new method for charting SARS-CoV-2 spike protein glycosylation

Researchers develop new method for charting SARS-CoV-2 spike protein glycosylation